DrugPatentWatch Database Preview
Sun Pharm Inds Company Profile
» See Plans and Pricing
What is the competitive landscape for SUN PHARM INDS, and when can generic versions of SUN PHARM INDS drugs launch?
SUN PHARM INDS has two hundred and eighteen approved drugs.
There are five US patents protecting SUN PHARM INDS drugs. There are five tentative approvals on SUN PHARM INDS drugs.
There are eleven patent family members on SUN PHARM INDS drugs in nine countries and one hundred and ninety-six supplementary protection certificates in sixteen countries.
Summary for Sun Pharm Inds
| International Patents: | 11 |
| US Patents: | 5 |
| Tradenames: | 162 |
| Ingredients: | 153 |
| NDAs: | 218 |
Drugs and US Patents for Sun Pharm Inds
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 091401-001 | Mar 28, 2013 | DISCN | No | No | Start Trial | Start Trial | |||||
| Sun Pharm Inds Inc | TECHNETIUM TC 99M SESTAMIBI | technetium tc-99m sestamibi kit | INJECTABLE;INJECTION | 079157-001 | Jul 10, 2009 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sun Pharm Inds Ltd | MORPHINE SULFATE | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 078761-005 | May 11, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Sun Pharm Inds Ltd | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076409-002 | Sep 16, 2003 | DISCN | No | No | Start Trial | Start Trial | |||||
| Sun Pharm Inds Ltd | ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 075556-002 | Aug 22, 2000 | DISCN | No | No | Start Trial | Start Trial | |||||
| Sun Pharm Inds Ltd | TOPIRAMATE | topiramate | TABLET;ORAL | 076327-003 | Mar 27, 2009 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Sun Pharm Inds Inc | CLONAZEPAM | clonazepam | TABLET, ORALLY DISINTEGRATING;ORAL | 078654-002 | Aug 27, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sun Pharm Inds
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | ULTRAVATE | halobetasol propionate | CREAM;TOPICAL | 019967-001 | Dec 27, 1990 | 4,619,921 | Start Trial |
| Sun Pharm Inds Inc | BACTRIM | sulfamethoxazole; trimethoprim | INJECTABLE;INJECTION | 018374-001 | Approved Prior to Jan 1, 1982 | RE28636 | Start Trial |
| Sun Pharm Inds Inc | BACTRIM | sulfamethoxazole; trimethoprim | INJECTABLE;INJECTION | 018374-001 | Approved Prior to Jan 1, 1982 | 3,551,564 | Start Trial |
| Sun Pharm Inds Inc | LAC-HYDRIN | ammonium lactate | LOTION;TOPICAL | 019155-001 | Apr 24, 1985 | 4,105,783 | Start Trial |
| Sun Pharm Inds Inc | ULTRAVATE | halobetasol propionate | OINTMENT;TOPICAL | 019968-001 | Dec 17, 1990 | 4,619,921 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM INDS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-01-07 |
| ➤ Subscribe | Capsules | 35 mg | ➤ Subscribe | 2015-11-25 |
| ➤ Subscribe | Capsules | 30 mg and 40 mg | ➤ Subscribe | 2012-12-31 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-06-19 |
| ➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2016-05-16 |
International Patents for Sun Pharm Inds Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Portugal | 1318791 | Start Trial |
| Australia | 8943801 | Start Trial |
| Canada | 2836228 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2015094574 | Start Trial |
| Canada | 2423170 | Start Trial |
| European Patent Office | 1318791 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0224172 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Inds Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2236132 | C300714 | Netherlands | Start Trial | PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718 |
| 0454511 | SPC/GB99/008 | United Kingdom | Start Trial | PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE)(GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/98/086/001 19981015; UK EU/1/98/086/002 19981015; UK EU/1/98/086/003 19981015; UK EU/1/98/086/004 19981015; UK EU/1/98/086/005 19981015; UK EU/1/98/086/006 19981015 |
| 0984957 | 122012000051 | Germany | Start Trial | PRODUCT NAME: KOMBINATIONSPRODUKT UMFASSEND NAPROXEN UND ESOMEPRAZOL-MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105 |
| 0443983 | C300445 | Netherlands | Start Trial | PRODUCT NAME: VALSARTAN, AMLODIPINE EN HYDROCHLOORTHIAZIDE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/09/569/001-060 20091016 |
| 0347066 | C300155 | Netherlands | Start Trial | PRODUCT NAME: ESCITALOPRAM, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVA ARDBAAR ZUURADDITIEZOUT, IN HET BIJZONDER ESCITALOPRAMOXALAAT; REGISTRATION NO/DATE: RVG 30490 - RVG 30497 20040427 |
| 0347066 | SPC/GB02/049 | United Kingdom | Start Trial | PRODUCT NAME: ESCITALOPRAM OXALATE; REGISTERED: SE 17084/85/86/87 20011207; UK PL 13761/0008 20020610; UK PC 13761/0009 20020610; UK PL 13761/0010 20020610; UK PL 13761/0011 20020610; UK PL 13761/0012 20020610; UK PL 13761/0013 20020610; UK PL 13761/00014 20020610; UK PL 13761/0015 20020610 |
| 0663828 | C300085 | Netherlands | Start Trial | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
